Research & Education

A survey of the general population in France identifies knowledge gaps in the perception of lung cancer.

DENVER – A prospective nationwide survey on perceptions of lung cancer in the general population of France highlights a need for increased public education on the benefits of lung cancer screening, the good survival rates of early-stage disease and the improved outcomes with new therapeutic strategies, including targeted-therapies.

Targeted next-generation sequencing reveals a high number of genomic mutations in advanced malignant plural mesothelioma.

DENVER – Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of mutations correlates with early progression of the tumor and decreased survival.

IASLC Supports the CMS Formal Proposal to Pay For Lung Cancer Screening

DENVER – The International Association for the Study of Lung Cancer (IASLC) is pleased that the Centers for Medicare & Medicaid Services (CMS) made a draft proposal Monday to cover low-dose CT screening of patients at high risk for lung cancer.

Interstitial lung disease is a significant risk factor for lung inflammation following stereotactic body radiation therapy for lung cancer.

DENVER – Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone.

Risk stratification model may aid in lung cancer staging and treatment decisions.

DENVER – A risk stratification model based on lymph node characteristics confirms with a high level of confidence the true lack of lung cancer in lymph nodes adequately sampled with endobronchial ultrasound-guided transbronchial needle aspiration and classified as negative.

Prognostic factors identified for peripheral squamous cell carcinomas of the lung.

DENVER – A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood vessels of individuals with a peripheral squamous cell carcinoma, a type of non-small cell lung cancer (NSCLC).